{ "cik": 1815776, "cik_padded": "0001815776", "entityName": "LENZ Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001815776-26-000011", "filed": "2026-03-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 827000.0, "cash": 25179000.0, "eps_diluted": -2.85, "free_cash_flow": -69997000.0, "net_income": -82127000.0, "operating_cash_flow": -69170000.0, "operating_income": -91138000.0, "revenue": 19088000.0, "stockholders_equity": 284339000.0, "total_assets": 305876000.0, "total_liabilities": 21537000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07574409419741927, "roa_avg2y": -0.3151579108945086, "roa_period_end": -0.26849769187513894, "roe_avg2y": -0.33629456434279303, "roe_period_end": -0.2888348063403191 } }, { "accn": "0001815776-26-000011", "filed": "2026-03-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 468000.0, "cash": 20158000.0, "eps_diluted": -2.34, "free_cash_flow": -59859000.0, "net_income": -49769000.0, "operating_cash_flow": -59391000.0, "operating_income": -58610000.0, "stockholders_equity": 204084000.0, "total_assets": 215304000.0, "total_liabilities": 11220000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05497736226259775, "roa_avg2y": -0.34842481097731726, "roa_period_end": -0.2311568758592502, "roe_avg2y": -0.8937434902848113, "roe_period_end": -0.2438652711628545 } }, { "accn": "0001815776-26-000011", "filed": "2026-03-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 30000.0, "cash": 35140000.0, "eps_diluted": -35.71, "free_cash_flow": -60410000.0, "net_income": -69968000.0, "operating_cash_flow": -60380000.0, "operating_income": -72429000.0, "stockholders_equity": -92712000.0, "total_assets": 70376000.0, "total_liabilities": 19698000.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.35672660715105103, "roa_period_end": -0.9942025690576333, "roe_avg2y": 1.197251905784516 } }, { "accn": "0001815776-25-000019", "filed": "2025-03-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6594000.0, "cash": 47730000.0, "eps_diluted": -1.84, "free_cash_flow": -94574000.0, "net_income": -101052000.0, "operating_cash_flow": -87980000.0, "operating_income": -105639000.0, "stockholders_equity": -24169000.0, "total_assets": 321902000.0, "total_liabilities": 25611000.0 }, "period_end": "2022-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.27919197556531455, "roa_period_end": -0.3139216283216631, "roe_avg2y": -0.5615856352516526 } }, { "accn": "0000950170-24-021135", "filed": "2024-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5740000.0, "cash": 376976000.0, "eps_diluted": -2.45, "free_cash_flow": -58592000.0, "net_income": -70760000.0, "operating_cash_flow": -52852000.0, "operating_income": -60443000.0, "stockholders_equity": 384050000.0, "total_assets": 401987000.0, "total_liabilities": 17937000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04670485613852363, "roa_avg2y": -0.3333403996221891, "roa_period_end": -0.17602559286743102, "roe_avg2y": -0.44413479704495956, "roe_period_end": -0.18424684285900272 } }, { "accn": "0000950170-23-008764", "filed": "2023-03-20", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1545000.0, "cash": 19782000.0, "free_cash_flow": -10266000.0, "net_income": -68373000.0, "operating_cash_flow": -8721000.0, "operating_income": -13500000.0, "stockholders_equity": -65408000.0, "total_assets": 22564000.0, "total_liabilities": 32364000.0 }, "period_end": "2020-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": 2.0220920947564545 } }, { "accn": "0001564590-22-011123", "filed": "2022-03-21", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -2218000.0 }, "period_end": "2019-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001815776-26-000011", "filed": "2026-03-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001815776.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001815776.json" }, "ticker": "LENZ" }